Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 11,442Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Erleada

PharmaCompass

01

Brand Name : Erleada

Apalutamide

arrow
CPhI India 2024
Not Confirmed

Brand Name : Erleada

arrow
CPhI India 2024
Not Confirmed

Apalutamide

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 760

2019 Revenue in Millions : 332

Growth (%) : 129

blank

02

Brand Name : Erleada

Apalutamide

arrow
CPhI India 2024
Not Confirmed

Brand Name : Erleada

arrow
CPhI India 2024
Not Confirmed

Apalutamide

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 1,291

2020 Revenue in Millions : 760

Growth (%) : 70

blank

03

Brand Name : Erleada

Apalutamide

arrow
CPhI India 2024
Not Confirmed

Brand Name : Erleada

arrow
CPhI India 2024
Not Confirmed

Apalutamide

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 1,881

2021 Revenue in Millions : 1,291

Growth (%) : 46

blank

04

Brand Name : Erleada

Apalutamide

arrow
CPhI India 2024
Not Confirmed

Brand Name : Erleada

arrow
CPhI India 2024
Not Confirmed

Apalutamide

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 2,387

2022 Revenue in Millions : 1,881

Growth (%) : 27

blank